An Open Label, Phase II Study of Capecitabine (Xeloda) Plus Conformal Radiotherapy for Patients With Locally Advanced, Non-Metastatic Rectosigmoid Carcinoma
Phase of Trial: Phase IV
Latest Information Update: 09 Nov 2007
At a glance
- Drugs Capecitabine (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 09 Nov 2007 Status changed from recruiting to discontinued. This study was terminated due to lack of accrual.
- 26 Nov 2005 New trial record.